FTC challenges $627M private equity takeover of Surmodics

The regulator said the buyout “would lead to a highly concentrated market for outsourced hydrophilic coatings and eliminate significant head-to-head competition.”

By Nick Paul Taylor • March 7, 2025

Illumina’s DNA sequencers hit with China import ban

Illumina is not banned from operating in the country and will continue to serve its existing customers, a company spokesperson said.

By Susan Kelly • March 6, 2025

Explore the Trendline➔

Medical device industry continues to turn to AI

While the industry continues to embrace artificial intelligence, there are still questions about how the new technologies need to be regulated and if they are effective.

By MedTech Dive staff

Boston Scientific leads $175M investment in 4C Medical

The money will support an ongoing pivotal trial of 4C Medical Technologies' transcatheter mitral valve replacement device in the U.S. and Europe.

By Nick Paul Taylor • March 6, 2025

Philips pulls endovascular implant from market after 20 injuries

Philips stopped selling its Tack endovascular system because of cases where additional interventions were needed to remove the implant.

By Elise Reuter • March 5, 2025

Trump’s trade war heats up as countries retaliate against tariffs

Mexico, Canada and China all announced they would counter the president's orders after additional duties went into effect this week.

By Philip Neuffer , Edwin Lopez , Max Garland • March 4, 2025

Staar Surgical names Stephen Farrell as CEO

Farrell replaces Tom Frinzi on the heels of a challenging year for the eye implant maker marked by a demand slowdown in China, its largest market.

By Susan Kelly • March 4, 2025

Medical device firms brace for effect of White House tariffs

President Donald Trump upped tariffs on China and said delayed tariffs on Mexico and Canada would take effect. Catch up on MedTech Dive’s latest coverage.

By Elise Reuter • March 4, 2025

Trump hikes tariffs on China by 10%

The president also maintained that the pause on duties for Canada and Mexico will come to an end Tuesday.

By Philip Neuffer • Updated March 3, 2025

Olympus recalls lung biopsy devices linked to 26 serious injuries

The FDA, which published a Class I recall notice, said the tip of the guide sheath has detached from some devices and fallen off in the patient.

By Nick Paul Taylor • March 4, 2025

FDA recall notice details J&J pause of Varipulse

Four of the 132 patients treated with Varipulse in the first two months of the U.S. launch had a form of stroke shortly after surgery.

By Nick Paul Taylor • March 3, 2025

Medtronic partners with Brainomix on AI stroke tool

Medtronic also recently teamed with Tempus to assess the use of artificial intelligence to identify people eligible for interventions like TAVR.

By Nick Paul Taylor • Feb. 28, 2025

Illumina to lay off 96 San Diego employees

The latest job cuts at Illumina’s California headquarters are not part of a broad-based reduction, a company spokesperson said.

By Susan Kelly • Feb. 28, 2025

Canada and Mexico tariffs will take effect March 4, Trump confirms

The president will also impose an additional 10% import tax on China next week and hinted at plans to soon levy 25% duties on the European Union.

By Philip Neuffer • Feb. 27, 2025

Teleflex to split in 2, buy Biotronik assets for $791M among slew of actions

Teleflex, whose shares sank nearly 20% Thursday, will acquire most of Biotronik’s vascular intervention assets. Teleflex also announced a CFO transition.

By Susan Kelly • Feb. 27, 2025

Tandem’s insulin pump tech wins FDA nod for Type 2 diabetes

Tandem is following competitor Insulet’s lead with the second automated insulin delivery system indicated for Type 2 diabetes.

By Elise Reuter • Feb. 27, 2025

Elekta CEO Gustaf Salford to leave after board sees need for new leader

Laurent Leksell, Elekta’s chairman of the board, said the company needs “new leadership that can further intensify the focus on improving profitability and strengthen growth.”

By Nick Paul Taylor • Feb. 27, 2025

Staar Surgical to lay off 115 people in California

Staar’s job cuts come “amid ongoing macroeconomic and geopolitical challenges that have pressured the business,” a spokesperson said. Demand in China, the company’s largest market, has slowed.

By Susan Kelly • Feb. 26, 2025

CAP urges HHS to revoke lab developed test rule, citing Trump order

The pathologists group wants the regulation terminated in light of an executive order from President Trump that calls for federal agencies to “alleviate unnecessary regulatory burdens.”

By Nick Paul Taylor • Feb. 26, 2025

Thermo Fisher to buy Solventum’s purification and filtration unit for $4.1B

Wall Street applauded the deal, sending shares of Solventum, the 3M spinoff, up 10% on Tuesday.

By Susan Kelly • Feb. 25, 2025

FDA brings back some fired device staff

An industry source said “most, if not all” of the people at the CDRH who were recently dismissed are now being asked to return.

By Elise Reuter • Feb. 24, 2025

Medtronic gains FDA OK for self-adjusting DBS system for Parkinson’s

The brain-computer interface technology personalizes therapy based on an individual’s brain activity.

By Susan Kelly • Feb. 24, 2025

After tough year, Baxter looks for next CEO to drive growth

Interim CEO Brent Shafer said the medical products maker is ready to begin a new era after several years of “heavy lifting” to simplify the business structure.

By Susan Kelly • Feb. 21, 2025

VitalConnect raises $100M for heart monitor patch

VitalConnect will use the money to commercialize the monitor, which detects arrhythmias and competes with patches from companies including iRhythm.

By Nick Paul Taylor • Feb. 21, 2025

Siemens Healthineers opening logistics depots in US to boost inventory

Expanding parts inventory and logistics capabilities will support later cutoff times, same-day delivery within 300 miles and more next-flight-out options for customers, the company said.

By Nick Paul Taylor • Feb. 20, 2025

Device industry scrambles as FDA job cuts cause delays

The cuts at the FDA’s device center could add “months, if not years” to the time it takes to bring products to market, an attorney said.

By Elise Reuter • Feb. 20, 2025